Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane M Devine

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal for Parasitology. Drugs and Drug Resistance|November 21, 2022
Current and emerging target identification methods for novel antimalarialsMatthew P Challis, Shane M Devine, Darren J Creek
Medchemcomm|August 16, 2018
Antimalarial drug discovery targeting apical membrane antigen 1Shane M Devine, Christopher A MacRaild, Raymond S Norton, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated heartsAnna Butcher, Peter J Scammells, Paul J White, et al.
Chemmedchem|November 13, 2019
A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer CellsCassandra Yong, Shane M Devine, Xuexin Gao, et al.
Molecular Pharmacology|June 27, 2013
Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptorPeter Keov, Celine Valant, Shane M Devine, et al.
Journal of Cardiovascular Pharmacology|June 24, 2010
A novel highly selective adenosine A1 receptor agonist VCP28 reduces ischemia injury in a cardiac cell line and ischemia-reperfusion injury in isolated rat hearts at concentrations that do not affect heart rateVijay B Urmaliya, Colin W Pouton, Shane M Devine, et al.
Journal of Medicinal Chemistry|August 30, 2018
Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic AgentsShane M Devine, Cassandra Yong, Dzifa Amenuvegbe, et al.
The Journal of Biological Chemistry|July 10, 2014
Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptorPeter Keov, Laura López, Shane M Devine, et al.
Journal of Medicinal Chemistry|February 10, 2012
Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptorCeline Valant, Luigi Aurelio, Shane M Devine, et al.
Clinical and Experimental Pharmacology & Physiology|July 6, 2016
VCP746, a novel A1 adenosine receptor biased agonist, reduces hypertrophy in a rat neonatal cardiac myocyte modelChung H Chuo, Shane M Devine, Peter J Scammells, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal for Parasitology. Drugs and Drug Resistance|November 21, 2022
Current and emerging target identification methods for novel antimalarialsMatthew P Challis, Shane M Devine, Darren J Creek
Medchemcomm|August 16, 2018
Antimalarial drug discovery targeting apical membrane antigen 1Shane M Devine, Christopher A MacRaild, Raymond S Norton, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated heartsAnna Butcher, Peter J Scammells, Paul J White, et al.
Chemmedchem|November 13, 2019
A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer CellsCassandra Yong, Shane M Devine, Xuexin Gao, et al.
Molecular Pharmacology|June 27, 2013
Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptorPeter Keov, Celine Valant, Shane M Devine, et al.
Journal of Cardiovascular Pharmacology|June 24, 2010
A novel highly selective adenosine A1 receptor agonist VCP28 reduces ischemia injury in a cardiac cell line and ischemia-reperfusion injury in isolated rat hearts at concentrations that do not affect heart rateVijay B Urmaliya, Colin W Pouton, Shane M Devine, et al.
Journal of Medicinal Chemistry|August 30, 2018
Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic AgentsShane M Devine, Cassandra Yong, Dzifa Amenuvegbe, et al.
The Journal of Biological Chemistry|July 10, 2014
Molecular mechanisms of bitopic ligand engagement with the M1 muscarinic acetylcholine receptorPeter Keov, Laura López, Shane M Devine, et al.
Journal of Medicinal Chemistry|February 10, 2012
Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptorCeline Valant, Luigi Aurelio, Shane M Devine, et al.
Clinical and Experimental Pharmacology & Physiology|July 6, 2016
VCP746, a novel A1 adenosine receptor biased agonist, reduces hypertrophy in a rat neonatal cardiac myocyte modelChung H Chuo, Shane M Devine, Peter J Scammells, et al.
Pageof 3